Getting help can be a challenge when you have idiopathic hypersomnia. The condition isn’t well-understood, and it’s hard to find a treatment that really works. To take control of your care, you need ...
Regulatory mechanisms mediated by non-coding RNAs provide valuable insights into the pathogenesis of idiopathic pulmonary fibrosis.
'She was crawling on her hands and tummy.' ...
Lung CT Biomarkers Linked to ILD Prognosis. E-LUNG CT biomarkers were linked to mortality and future lung function decline in ...
Michael Thorpy, MD, professor of neurology, Albert Einstein College of Medicine explores the current treatment landscape of idiopathic hypersomnia and the associated challenges with approving new ...
Spherix Global Insights highlights rising enthusiasm for Priovant’s TYK2/JAK1 inhibitor alongside continued dissatisfaction ...
Topline results from the phase 3 REVITALYZ study show sodium oxybate extended release improves daytime sleepiness in idiopathic hypersomnia.
Many people with idiopathic hypersomnia (IH) experience depressive symptoms. The cause of IH is unknown, so it’s hard to say whether one condition causes the other. Many people with idiopathic ...
Julie Bloch Johnson, 32, spent years thinking her daytime sleepiness was normal. Sure, sometimes she needed to pinch herself to stay awake, and she could take a nap anytime she closed her eyes. But ...
The IPF market is expanding due to rising demand for effective treatments, driven by aging populations and medical innovations. Key players like Boehringer Ingelheim and Roche dominate with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results